Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: David S. who wrote (1244)	3/8/1998 3:09:00 PM
From: Ron Harvey	Read Replies (1) \| Respond to of 5736

<<The chromatic color device was approved last summer. How many have they sold?>> Oh, c'mon. You know this is disingenuous. And you know (I hope) that ultimately, with virtually any new, market-unproven product, future achievements are always a matter of speculation. Successful companies, by definition, do far better than the naysayers expect and reward early investors, sometimes mightily, and companies that fail, sometimes despite glowing opportunity, confirm the dire predictions of bears. But reading the future with surety is obviously denied to all of us. So we conjecture about prospects, not just what an unknown future will produce, but about how perceptions of that future will balance out in a current stock price. So far, positive perceptions about Chromatics are on a roll and will probably continue at least into a deal announcement, the nature of which will trigger the next set of perceptions. Only until longer-term fundamentals actually begin to manifest themselves will there be something substantive to base yet a new set of perceptions on. These are both the frustrations and the fun of the game. What we do is bet our money one way or the other and then hope, but we don't really know. . . . (My psychic visions, of course, are the only exception.)